Drug abuse is characterized by a self-destructive pattern that can result into other medical conditions. Drug abuse is harmful and can increase the risk of a number of mental health conditions. The physical and psychological effects of drug abuse can vary. However, the general effects of addiction to any drug is devastating.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2011
Increasing number of addicted population, and increasing product launches are expected to drive the global drug abuse treatment market.
Rising number of drug abuse and dependence on drugs in key regions such as North America is expected to increase the demand for its treatment in the near future. North America held the dominant position in the global drug abuse treatment market owing to the high rates of drug abuse in the region and is expected to retain its dominance during the forecast period (2018 – 2026). According to the National Survey on Drug Use and Health (NSDUH), around 19.7 million 12 years or older individuals in the U.S. struggled with substance use disorder in 2017. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), around 830,000 people in the U.S. used heroin in 2015, which is more than double in comparison to 2002. Such increasing rates of drugs abuse are anticipated to propel the growth of the global drug abuse treatment market in the near future.
Key players are focusing on product launches of novel drugs for the treatment of drug abuse, which is expected to boost the global drug abuse treatment market in the near future. For instance, in 2015, Mylan N.V., a pharmaceutical company, launched its new drugs Disulfiram Tablets USP, 250 mg and 500 mg, which is indicated for the treatment of chronic alcohol patients, in the U.S. market. In 2017, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, launched Kwitz, a new nicotine replacement therapy, in India.
Global Drug Abuse Treatment Market: Competitive Landscape
Key players operating in the global drug abuse treatment market include British American Tobacco Plc., Cipla Limited, Mylan N.V., Pfizer Inc., Odyssey Pharmaceuticals Inc., Indivior Plc., Lil’ Drug Store Products Inc., Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals, and Teva Pharmaceutical Industries Ltd.
Global Drug Abuse Treatment Market: Key Market Trends
In April 2018, Lil’ Drug Store Products Inc. launched its Nicotac brand nicotine gum in the market. In 2017, Cipla Health, an arm of Cipla Limited, launched a new Nicotex Nicotine Patches. Nicotex Nicotine Patches are skin/transdermal patches available in three strengths 21 mg, 14mg, and 7 mg, which aids people to quit smoking within 12 months.
Segmentation:
Global Drug Abuse Treatment Market Taxonomy:
- By Abuse Type
- Alcohol Dependence
- Tobacco/Nicotine Addiction
- Opioid Addiction
- By Drug Type
- Disulfiram
- Acamprosate
- Naltrexone
- Methadone
- Buprenorphine
- Nicotine Addiction Treatment
- Others
- By Distribution Channel
- Hospital
- Retail Pharmacy
- Online Pharmacy
- By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/2011
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837